Exagen_Full_CMYK_Print.jpg
Exagen and GSK partner for 4th straight year, driving greater awareness of challenges facing lupus diagnosis and management
November 16, 2020 08:25 ET | Exagen Inc.
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen_Full_CMYK_Print.jpg
Exagen Showcases Six Scientific Presentations at ACR’s First Virtual Annual Meeting in November 2020
October 21, 2020 16:05 ET | Exagen Inc.
SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced...
Exagen_Full_CMYK_Print.jpg
Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)
September 21, 2020 08:25 ET | Exagen Inc.
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
September 03, 2020 16:05 ET | Exagen Inc.
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome
August 03, 2020 16:05 ET | Exagen Inc.
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Reports Second Quarter 2020 Results
July 28, 2020 07:00 ET | Exagen Inc.
Testing Experiencing Monthly Sequential ImprovementRecord Gross Margins of 63% SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
July 27, 2020 16:05 ET | Exagen Inc.
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia
June 17, 2020 08:25 ET | Exagen Inc.
SAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen to Present at the William Blair 40th Annual Growth Stock Conference
May 26, 2020 08:25 ET | Exagen Inc.
SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
March 25, 2020 16:05 ET | Exagen, Inc.
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...